MYRIAD GROUP AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - CHF | -.--% |
|
-27.92% | -62.93% |
| 04-11 | Syncona to Sell Stake in Portfolio Company to Century Therapeutics | MT |
| 02-20 | Syncona’s Takeover of Freeline Therapeutics Becomes Effective | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Software
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 0 | - | - | - | - | - | |
| 3,085B | ||||||
| 85.92B | ||||||
| 77.91B | ||||||
| 52.89B | ||||||
| 48.28B |
- Stock Market
- Equities
- MYRN Stock
- Charts Myriad Group AG
- Sector Chart
